Can-Fite BioPharma Ltd.
CANF- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001536196
No open-market purchases or sales by Can-Fite BioPharma Ltd. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $149.1K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Can-Fite BioPharma Ltd. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 16 | 16 | 0 |
| Shares | 905.0K | 1.54M | +633.6K (+70.0%) |
| Value | $950.1K | $952.6K | +$2.49K (+0.3%) |
New holders (2)
Institutions that held Can-Fite BioPharma Ltd. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bogart Wealth, LLC | 15,045 | $9.32K | 0.00% |
| EverSource Wealth Advisors, LLC | 68 | $42 | 0.00% |
Sold out (2)
Institutions that held Can-Fite BioPharma Ltd. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Advisor Group Holdings, Inc. | 180 | $189 |
| Bank of America Corp | 6 | $6 |